Zylox-Tonbridge (02190) announced that on November 6, 2026, Lifetech Scientific (01302) intends to issue approximately 926 million target company shares to Lighthouse SPV, representing about 16.7% of the target company's total issued share capital as enlarged by the allotment and issuance of Lifetech shares, for a total consideration of approximately HK$1,482.1 million. The company intends to subscribe for Lighthouse shares, representing about 60.0% of Lighthouse SPV's total issued share capital as enlarged by the allotment and issuance of Lighthouse shares, for a consideration of approximately HK$889.3 million.
Upon completion of the proposed transaction, the company will (i) indirectly hold approximately 16.7% of the voting rights in Lifetech Scientific (01302) through its 60.0% equity interest in Lighthouse SPV; and (ii) indirectly hold approximately 10.0% of the beneficial interest in Lifetech Scientific (01302). The board believes the proposed transaction will help establish a leading China vascular intervention platform and enhance the group's business scale across four treatment areas in the vascular intervention market, namely neurovascular intervention, peripheral vascular intervention, aortic intervention, and structural heart disease intervention. This will further strengthen the group's market penetration in both domestic and global markets. Subject to compliance with all applicable laws and regulations, and when market conditions permit, the company may consider increasing its equity interest in the target company in the future.
On the same day, the company entered into a new H-share subscription agreement with GL Lighthouse Three, under which the company intends to allot and issue 39.8 million new H shares to GL Lighthouse Three at HK$22.0 per new H share. The issue price represents a premium of approximately 13.5% over the closing price of HK$19.390 per new H share as quoted on the Stock Exchange on November 6, 2026. Net proceeds of approximately HK$864 million will be used for potential investments or acquisitions to drive the group's long-term business development.
As at the date of this announcement, Lighthouse SPV is wholly owned by GL Lighthouse One. GL Lighthouse Three is principally engaged in investment holding and is wholly owned by GL Lighthouse One. Upon completion of the proposed transaction, Lighthouse SPV will be held 60.0% by the company and 40.0% by GL Lighthouse One. Immediately following completion of the proposed new H-share issuance, GL Capital entities are expected to become substantial shareholders of the company in aggregate. GL Capital entities refer collectively to GL Trade Investment IV L.P. and GL Lighthouse Three.
Comments